Search
-
Ipsos Core Political Survey: Presidential Approval Tracker (07/15/2021)
President Biden’s approval remains steady with a little over half of Americans approving of his job in office
-
[WEBINAR] Pharma utilization and cost management for self-funded employers
With rising prescription drug costs increasingly due to cell, gene and other high cost therapies, employers are exploring various approaches to managing drug utilization and spend by their employees. Join us for a complimentary webinar as we explore this topic in detail and outline implications to market access strategy development.
-
World Youth Skills Day 2021: Worse mental health and wellbeing are seen as long-lasting outcomes
On average, almost 4-in-10 across 29 countries think worse mental health and wellbeing among children and young people will be a long-lasting outcome of the pandemic.
-
Small business owners expect six months to a year before return to normal
A MetLife/U.S. Chamber of Commerce Small Business Special Report shows most small businesses are not actively looking to hire, and those who are struggle to find workers with the needed skills and experience
-
Three quarters of Americans with health insurance coverage believe too many hurdles exist between patients and doctor-prescribed medicines
New Ipsos poll conducted with Novartis finds that 92% of patients believe that doctors should be making therapy decisions, not insurers
-
Ipsos Core Political Survey: Presidential Approval Tracker (07/08/2021)
Little over half of Americans continue to approve of President Biden's job in office
-
Reuters/Ipsos Poll: Big Government
Americans are divided on how much the government should get involved in major issues
-
American greatness gets mixed reviews
On America’s 245th birthday, the country is split on how great the United States really is.
-
Back on Track: Reversing the Impact of COVID on PREP
Discover the potential impact of pandemic-induced restrictions on access to HIV therapies such as PrEP (pre-exposure prophylaxis).
-
The Other Side of the Story
Read insights exploring COVID-19 treatment developments, including treatment landscape and how they are being used in real-world clinical practice.